News Archives - Oxford

ARC Oxford’s Oxbotica unveils new brand, as company scales globally

Ultromics granted FDA Breakthrough Device Designation

Biotech company Oxford BioDynamics awarded $963,000

OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth

ARC Oxford becomes latest member of Advanced Oxford

ARC gets lab space down to a science

Oxbotica partnership to take autonomous deliveries to Europe

Scientists create new blood test for prostate cancer that is 94% accurate

Perspectum Completes $36 Million First Close of Series C Funding

Accession Therapeutics raises funding

Growing tomorrow’s innovators

Welcoming ARC Oxford

you've seen 12 of 14 News

1
2